Mots-clés
Documents disponibles dans cette catégorie (32)
Périodique
Y. LECOMPTE ; O. ROUSSEL ; M. PERRIN | 2008FRANÇAIS : La 1-benzylpipérazine (BZP) et la 1-(3-trifluorométhylphényl)pipérazine (TFMPP) sont des substances psychoactives apparues en France, sur le marché des produits illicites, au cours de lannée 2006. Ces molécules sont employées dans le[...]Périodique
M. WIKSTROM ; P. HOLMGREN ; J. AHLNER | 2004N-Benzylpiperazine was tested in the beginning of the 1970s as a possible antidepressant drug. However, in both animal and human studies, it was shown to possess amphetamine-like properties, and any further studies were stopped. In a forensic au[...]Rapport
Drug matters appear high on the political agenda of the European Union. In the last decade, two successive European Union Drug Strategies and their related Action Plans were endorsed and implemented. In the area of synthetic drugs, a specific Ac[...]Texte legislatif
EXTRAIT Article 1. - A l'annexe IV de l'arrêté du 22 février 1990 susvisé, il est ajouté : BZP ou benzylpipérazine.Article : Périodique
N-benzylpiperazine (BZP) is the active ingredient in recreational 'party' or 'p.e.p.' pills, which are used to provide a stimulant, euphoric effect akin to that of methylenedioxymethamphetamine (MDMA, 'ecstasy'). BZP predominantly affects dopami[...]Article : Périodique
FRANÇAIS : Molécule aux effets comparables aux amphétamines, la BZP (ou 1-benzylpipérazine) n'a pas d'indication thérapeutique mais fait l'objet d'un usage récréatif, en particulier en Nouvelle-Zélande. Quasiment inconnue en France, elle va po[...]Article : Périodique
Background BZP-party pills are yet another 'designer drug' which mimics the stimulant qualities of amphetamines and MDMA/Ecstasy. As legal markets for the substance have developed in the last decade (especially amongst young people) so has publi[...]Article : Périodique
INTRODUCTION. Novel synthetic 'designer' drugs with stimulant, ecstasy-like (entactogenic) and/or hallucinogenic properties have become increasingly popular among recreational drug users in recent years. The substances used change frequently in [...]Article : Périodique
Rapport
OMS / WHO | Genève : OMS / WHO | Rapports techniques / Technical report series, ISSN 0512-3054 | 2012FRANÇAIS : Le présent rapport contient les recommandations d'un comité OMS d'experts chargé d'étudier les données relatives aux substances psychoactives afin de déterminer dans quelle mesure il pourrait être nécessaire de les placer sous contrô[...]Article : Périodique
H. CAMPBELL ; W. CLINE ; M. EVANS ; J. LLOYD ; A. W. PECK |The subjective, behavioural and autonomic effects of dexamphetamine 10 mg, 1-benzylpiperazine 100 mg and lactose dummy were compared in a group of 18 former amphetamine addicts. All subjects received the three preparations according to a balance[...]Texte legislatif
EXTRAIT La BZP est une substance de synthèse. Elle a été signalée pour la première fois dans l'Union européenne en 1999. Comme l'amphétamine et la méthamphétamine, la BZP est un stimulant du système nerveux central mais sa puissance est netteme[...]Rapport
Au sein du pôle TREND (Tendances récentes et nouvelles drogues) de l'OFDT, les enquêtes observation du dispositif SINTES permettent d'apporter un éclairage sur la composition des substances illicites telles qu'elles sont consommées par les usage[...]Article : Périodique
One unintended consequence of current medicines legislation is to leave distributors of 'legal highs' unable to disclose the true purpose of their product. General commonsense precautions that apply to any psychoactive drug cannot be given witho[...]Article : Périodique
Recently, a new class of "designer drugs" has emerged on the drug use market, known as "legal highs" or "herbal highs". They include a wide range of products, from natural plant-originated substances to synthetic compounds, that can be purchased[...]Rapport
A. WINSTOCK ; C. WILKINS | Amsterdam : Transnational Institute (TNI) | Series on legislative reform of drug policies | 2011FRANÇAIS : Ce document de l'IDPC et du Transnational Institute (TNI) cherche à définir les enjeux politiques et de santé publique créés par l'émergence de nouvelles substances psychoactives. Ces substances, communément appelées « drogues légal[...]Rapport
This Regulatory Impact Statement has been prepared by the Ministry of Health. Current legislation has proved ineffective in dealing with the rapid growth in new psychoactive substances, such as party pills and other legal highs, which can be sy[...]Livre
P. I. DARGAN, Éditeur scientifique ; D. M. WOOD, Éditeur scientifique | London : Academic Press - Elsevier | 2013"Novel Psychoactive Substances: Classification, Pharmacology and Toxicology" provides readers with background on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." This book[...]Article : Périodique
Since the turn of the 21st century, there has been an increase in the availability and use of novel psychoactive substances (also known as "legal highs") across Europe. Currently, there is limited information available on the potential acute tox[...]Rapport
This paper is intended to provide the basis for a discussion of policy options in dealing with new psychoactive substances that show signs of popularity and of harmfulness within a wider project being undertaken by the UK Drug Policy Commission [...]Article : Périodique
Périodique
T. C. NICHOLSON | 2006ENGLISH : The aim of the present study was to establish the prevalence of use, epidemiology and toxicity of 'herbal party pills' in ED presenters. This was an analytical cross-sectional survey of patients and relatives presenting to a large te[...]Article : Périodique
S. DAVIES ; D. M. WOOD ; G. SMITH ; J. BUTTON ; J. RAMSEY ; R. ARCHER ; D. W. HOLT ; P. I. DARGAN |Background: The supply of recreational drugs has changed and users increasingly buy 'legal highs' over the Internet. Use of these is common and there is a potential for significant toxicity associated with their use. Aim: To determine the conte[...]Rapport
ENGLISH : This publication presents the findings of the formal risk assessment on BZP, produced in 2007 by the Scientific Committee of the EMCDDA, with participation of additional experts from the European Commission, Europol and the EMEA. The[...]Article : Périodique
C. B. McNABB ; B. R. RUSSELL ; D. CAPRIOLI ; D. J. NUTT ; S. GIBBONS ; J. W. DALLEY |A recent and dramatic increase in the emergence of novel psychoactive substances ('legal highs') has left many governments unable to provide a timely response to an increasing number of potentially harmful drugs now available to the public. In r[...]Article : Périodique
J. SHERIDAN ; C. Y. DONG ; R. BUTLER ; J. BARNES |Background: The last decade has seen the emergence of a new phenomenon in recreational substance use with the availability of herbal and synthetic, unregulated, psychoactive drugs in the market place; alongside this, international concern has de[...]Article : Périodique
Background: Legal highs containing benzylpiperazine (BZP) were widely sold in New Zealand until BZP was prohibited in 2008. We examined the impact the prohibition had on the availability and price of BZP over following years. Methods: Two nati[...]Article : Périodique
Background: Benzylpiperazine (BZP) is the psychoactive ingredient in a range of ‘legal highs' sold worldwide. BZP was prohibited in New Zealand in 2008. Aim: To investigate the impact of the prohibition of BZP legal highs on the prevalence of [...]Article : Périodique
ENGLISH : Piperazine-based 'party pills' containing 1-benzylpiperazine (BZP) and 1-(m-trifluorophenylmethylphenyl)piperazine (TFMPP) have become increasingly popular in New Zealand and many other countries. The aim of this study was to collect[...]Rapport
OMS / WHO | Genève : OMS / WHO | Rapports techniques / Technical report series, ISSN 0512-3054 | 2015This report presents the recommendations of the thirty-sixth WHO Expert Committee on Drug Dependence (ECDD). The ECDD is responsible for the assessment of therapeutic usefulness, the liability to abuse and dependence and the public health and so[...]Rapport
OMS / WHO | Genève : OMS / WHO | Rapports techniques / Technical report series, ISSN 0512-3054 | 2016The WHO Expert Committee on Drug Dependence (ECDD) is responsible for assessing psychoactive substances for possible control under the international drug control conventions. The ECDD reviews the therapeutic usefulness, the liability for abuse a[...]